Form 8-K - Current report:
SEC Accession No. 0001104659-12-067249
Filing Date
2012-10-03
Accepted
2012-10-03 13:21:29
Documents
7
Period of Report
2012-10-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-22470_48k.htm 8-K 41656
2 EX-1.1 a12-22470_4ex1d1.htm EX-1.1 174478
3 EX-5.1 a12-22470_4ex5d1.htm EX-5.1 8877
4 EX-99.1 a12-22470_4ex99d1.htm EX-99.1 9677
5 EX-99.2 a12-22470_4ex99d2.htm EX-99.2 118975
6 GRAPHIC g224704mmi001.jpg GRAPHIC 7218
7 GRAPHIC g224704kmi001.jpg GRAPHIC 1980
  Complete submission text file 0001104659-12-067249.txt   367687
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 121126006
SIC: 2834 Pharmaceutical Preparations